Long-acting insulin to reduce cardiovascular morbidity and mortality in pre-diabetic patients and patients with type 2 diabetes.

摘要

"Long-acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes". The present invention relates to a method for reducing cardiovascular morbidity and mortality in a Type 2 or pre-diabetic patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a Type 2 or pre-diabetic Diabetes patient.